1. Anna Lembke was born on November 27,1967 and is an American psychiatrist practicing in the field of addiction medicine who is chief of the Stanford Addiction Medicine Dual Diagnosis Clinic at Stanford University.
13 Facts About Anna Lembke
1. 2.
Anna Lembke is a specialist in the opioid epidemic in the United States and the author of Drug Dealer, MD, How Doctors Were Duped, Patients Got Hooked, and Why It's So Hard to Stop.
3.
Anna Lembke interned at the Alameda County Highland Hospital, specializing in adult psychiatry and addiction.
4.
At Stanford University School of Medicine, Anna Lembke is professor and medical director of addiction medicine.
5.
Anna Lembke is program director of the Stanford Addiction Medicine Fellowship.
6.
Anna Lembke is chief of the Stanford Addiction Medicine Dual Diagnosis Clinic, whose mission is to support patients with substance use disorders, behavioral addictions, and co-occurring psychiatric disorders.
7.
Anna Lembke has published more than a hundred professional papers, authored many commentaries and book chapters, traveled around the United States giving lectures, and delivered expert testimony to legislators.
8.
Anna Lembke delivered a TED talk on the opioid epidemic and pain management at TEDx Stanford.
9.
Anna Lembke has studied addiction in relation to substances such as drugs and alcohol, but she has taken special interest in addictions to smartphones and other technology.
10.
Anna Lembke believed COVID-19 brought on a cultural shift that not only increased awareness towards addiction as a whole, but specifically in regards to digital and social media.
11.
Anna Lembke appeared in the 2020 Netflix docudrama The Social Dilemma, in which she argued that "social media is a drug" that exploits the brain's evolutionary need for interpersonal connection.
12.
Anna Lembke's children appeared in the film, and family members commented that they believe most people significantly underestimate their screen time.
13.
Anna Lembke argues that dopamine is important to the brain, but drugs short-circuits the process to receiving dopamine.